Wells Fargo Maintains Overweight on Incyte, Raises Price Target to $116

Benzinga · 2d ago
Wells Fargo analyst Derek Archila maintains Incyte (NASDAQ:INCY) with a Overweight and raises the price target from $97 to $116.